Indianapolis, IN, United States of America

Brian Paul McCarthy

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Indiana University. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian Paul McCarthy: Innovator in Bioreactor Technology

Introduction

Brian Paul McCarthy is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of bioreactor technology, focusing on innovative methods for biofabrication. His work aims to enhance the development of perfusible tissue constructs, which are crucial for various biomedical applications.

Latest Patents

Brian Paul McCarthy holds a patent for a bioreactor that comprises a housing defining a perfusion chamber. This housing includes at least one port that is coupled to the housing, along with a sample holder positioned within the perfusion chamber. His invention also encompasses a spheroid-based biofabrication method for creating perfusible tissue constructs and for perfusing them. This patent represents a significant advancement in the field of tissue engineering.

Career Highlights

Brian is affiliated with Indiana University, where he continues to engage in research and development related to his patented technology. His work is instrumental in pushing the boundaries of biotechnological applications in medicine.

Collaborations

Brian has collaborated with notable colleagues, including Lester Jeshua Smith and Mark Robert Holland. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Brian Paul McCarthy is a notable inventor whose work in bioreactor technology is paving the way for advancements in tissue engineering. His contributions are vital for the future of biomedical research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…